NYMXFHealthcare
NYMOX PHARMACEUTICAL CORP Insider Trading Activity
Every SEC Form 4 insider transaction reported for NYMOX PHARMACEUTICAL CORP (NYMXF), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are NYMXF insiders buying or selling?
NYMOX PHARMACEUTICAL CORP insiders reported 53 open-market buys ($2.8M) and 2 sells ($4.4M) across 55 Form 4 filings — a net selling position of $1.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 26, 2023)
Total Form 4 filings
55
SEC EDGAR
Insider filers
4
Insider buys (53)
$2.8M
Insider sells (2)
$4.4M
Insider sentiment
Net sellingNet insider flow of $1.6M in net selling.
Recent NYMXF insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 26, 2023 | James George Robinson | Director, 10% Owner | Purchase | 80.0K | $0.46 | $36.8K |
| May 18, 2023 | James George Robinson | Director, 10% Owner | Purchase | 40.0K | $0.45 | $18.0K |
| May 6, 2022 | James George Robinson | Director | Purchase | 1.2M | $1.65 | $1.9M |
| Apr 27, 2021 | James George Robinson | Director | Purchase | 40.0K | $2.08 | $83.3K |
| Jul 12, 2019 | James George Robinson | Director | Purchase | 7.0K | $1.73 | $12.1K |
| Jul 10, 2019 | James George Robinson | Director | Purchase | 7.0K | $1.63 | $11.4K |
| Jul 9, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.45 | $13.0K |
| Jul 3, 2019 | James George Robinson | Director | Purchase | 8.0K | $1.54 | $12.4K |
| Jul 2, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.37 | $12.3K |
| Jul 1, 2019 | James George Robinson | Director | Purchase | 10.0K | $15.16 | $151.6K |
| Jun 28, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.56 | $14.0K |
| Jun 27, 2019 | James George Robinson | Director | Purchase | 8.0K | $1.71 | $13.7K |
| Jun 26, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.73 | $15.5K |
| Jun 21, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.77 | $15.9K |
| Jun 20, 2019 | James George Robinson | Director | Purchase | 8.0K | $1.69 | $13.5K |
| Jun 19, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.67 | $15.0K |
| Jun 18, 2019 | James George Robinson | Director | Purchase | 8.0K | $1.42 | $11.3K |
| Jun 12, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.46 | $13.1K |
| Jun 12, 2019 | James George Robinson | Director | Purchase | 8.0K | $1.54 | $12.3K |
| Jun 7, 2019 | James George Robinson | Director | Purchase | 10.0K | $1.56 | $15.6K |
| Jun 6, 2019 | James George Robinson | Director | Purchase | 11.0K | $1.55 | $17.1K |
| Jun 4, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.62 | $14.6K |
| Jun 4, 2019 | James George Robinson | Director | Purchase | 10.0K | $1.59 | $15.9K |
| May 31, 2019 | James George Robinson | Director | Purchase | 8.5K | $1.76 | $15.0K |
| May 30, 2019 | James George Robinson | Director | Purchase | 9.0K | $1.68 | $15.1K |
Showing the 25 most recent of 55 Form 4 filings for NYMOX PHARMACEUTICAL CORP.
Most active NYMXF insiders
- James George Robinson50 filings
- Erik Danielsen2 filings
- Paul Averback2 filings
- Randall J Lanham1 filing
Ask anything about NYMXF insider activity
Use Trabud's AI agent to query NYMOX PHARMACEUTICAL CORP's Form 4 history in plain English — "Show me NYMXF CEO purchases this year" or compare it against any other ticker.
Open the AI agentNYMXF insider trading FAQ
Are NYMOX PHARMACEUTICAL CORP insiders buying or selling?
Across 55 SEC Form 4 filings, NYMOX PHARMACEUTICAL CORP (NYMXF) insiders reported 53 open-market purchases totaling $2.8M and 2 sales totaling $4.4M. That is a net selling position of $1.6M.
How many insiders trade NYMXF stock?
4 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NYMOX PHARMACEUTICAL CORP. The most recent filing was accepted on Jun 26, 2023.
Where does Trabud get NYMXF insider trading data?
All NYMXF insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.